Cole B J, Hillmann M, Seidelmann D, Klewer M, Jones G H
Department of Neuropsychopharmacology, Research Laboratories of Schering AG, Berlin, Germany.
Psychopharmacology (Berl). 1995 Sep;121(1):118-26. doi: 10.1007/BF02245598.
The present series of experiments examined the effects of five benzodiazepine receptor (BZR) partial inverse agonists on the behaviour of rats on an elevated plus maze. The drugs were tested in a standard plus maze with 3-cm walls added to the open arms, as this has been shown to increase the sensitivity of the plus maze to anxiogenic-like drugs effects (Jones and Cole 1995). The drugs tested were FG 7142 (0-100 mg/kg), beta-CCE (0-30 mg/kg), ZK 132,556 (0-100 mg/kg), ZK 90 886 (0-30 mg/kg) and Ro 15-4513 (0-30 mg/kg). In addition, to allow a comparison with previous studies, the effects of three reference substances, DMCM (0-2.5 mg/kg), pentylenetetrazol (PTZ; 0-30 mg/kg) and yohimbine (0-5 mg/kg), were also examined. These three reference compounds produced a dose-dependent reduction in the duration of open arm exploration and the total number of open arm entries, indicative of anxiogenic-like effects. DMCM produced significant effects at the doses of 1.25 and 2.5 mg/kg, PTZ at 30 mg/kg, and yohimbine at 5 mg/kg. The BZR partial inverse agonist FG 7142 (10, 30 and 100 mg/kg) also reduced the duration of open arm exploration and the total number of arm entries. The minimally effective dose resulted in a receptor occupancy of approximately 80%. Ro 15-4513 also produced anxiogenic-like effects, but only at a dose (30 mg/kg) that resulted in a receptor occupancy of approximately 95%.(ABSTRACT TRUNCATED AT 250 WORDS)
本系列实验研究了五种苯二氮䓬受体(BZR)部分反向激动剂对大鼠在高架十字迷宫中行为的影响。这些药物在标准十字迷宫中进行测试,该迷宫的开放臂添加了3厘米高的侧壁,因为已有研究表明,这样能提高十字迷宫对类焦虑药物效应的敏感性(琼斯和科尔,1995年)。所测试的药物有FG 7142(0 - 100毫克/千克)、β-CCE(0 - 30毫克/千克)、ZK 132,556(0 - 100毫克/千克)、ZK 90 886(0 - 30毫克/千克)和Ro 15 - 4513(0 - 30毫克/千克)。此外,为了与之前的研究进行比较,还研究了三种参考物质的影响,即DMCM(0 - 2.5毫克/千克)、戊四氮(PTZ;0 - 30毫克/千克)和育亨宾(0 - 5毫克/千克)。这三种参考化合物均使开放臂探索时间和进入开放臂的总次数呈剂量依赖性减少,表明具有类焦虑效应。DMCM在1.25毫克/千克和2.5毫克/千克剂量时产生显著效应,PTZ在30毫克/千克时产生显著效应,育亨宾在5毫克/千克时产生显著效应。BZR部分反向激动剂FG 7142(10、30和100毫克/千克)也减少了开放臂探索时间和进入臂的总次数。最小有效剂量导致受体占有率约为80%。Ro 15 - 4513也产生了类焦虑效应,但仅在导致受体占有率约为95%的剂量(30毫克/千克)时出现。(摘要截断于250字)